Skandinaviska Enskilda Banken AB »

Immunovant shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.9M 277k 32.23
2023-09-30 $26M 682k 38.39
2023-06-30 $9.9M 521k 18.97

More positions owned by Skandinaviska Enskilda Banken AB

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Merck & Co (MRK)
Advanced Micro Devices (AMD)
Mastercard Incorporated Cl A (MA)
Abbvie (ABBV)
Eli Lilly & Co. (LLY)
Adobe Systems Incorporated (ADBE)
UnitedHealth (UNH)

View all positions for Skandinaviska Enskilda Banken AB

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Perceptive Advisors
Armistice Capital
T. Rowe Price Associates
Viking Global Investors
Logos Global Management
Alpine Partners VI
Point72 Asset Management
Geode Capital Management
Woodline Partners
Fred Alger Management
Pictet Asset Management Holding SA
Rock Springs Capital Management

View all funds holding Immunovant